News – Oxford Sciences Innovation

Updates

Oxford Sciences Innovation @OSI_Updates·

Big welcome today to John McHutchison who joins the board of @EvOx_Ltd as OSI's representative. John is a highly experienced life science executive and will be invaluable as @EvOx_Ltd advance their exosome therapeutics into the clinic. Read more: https://www.evoxtherapeutics.com/News/Jan-2021/John-McHutchison-Joins-Evox-Board

Reply on Twitter 1351113649927180292 Retweet on Twitter 1351113649927180292 Like on Twitter 13511136499271802926 Twitter 1351113649927180292

Retweet on Twitter Oxford Sciences Innovation Retweeted

Perspectum @PerspectumGroup·

14 Jan

We are proud to announce the world’s first integrated imaging service for Long Covid has been approved by the UK’s MHRA.

#longcovid #coverscan #perspectum #medtech #healthcare

Read more: https://perspectum.com/news/world-s-first-integrated-imaging-service-for-long-covid-approved-by-uk-s-mhra

Reply on Twitter 1349755052861378561 Retweet on Twitter 134975505286137856112 Like on Twitter 134975505286137856122 Twitter 1349755052861378561

Oxford Sciences Innovation @OSI_Updates·

15 Jan

Approval from @MHRAgovuk for @PerspectumGroup’s CoverScan MD for #LongCovid 👏

Congratulations Perspectum and thank you for bringing us more good news in the fight against #COVIDー19!

Read more: https://bit.ly/3srlyrQ

Reply on Twitter 1350019534850240517 Retweet on Twitter 13500195348502405173 Like on Twitter 135001953485024051711 Twitter 1350019534850240517

Stay up to date with the OSI community

John McHutchison joins the board of Evox Therapeutics

Perspectum’s CoverScan MD approved by the UK’s MHRA – the world’s first integrated imaging service capable of mapping the impact of COVID-19 on the body

Ex-Centrica and BP boss Iain Conn joins Oxford Flow board

OQC lab takes delivery of first Proteox worldwide – a significant milestone to building a quantum-powered future

OQC state-of-the-art quantum laboratory opens

Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies

Ultromics’ first-of-a-kind AI solution to help clinicians diagnose coronary artery disease from echiocardiograms in a matter of minutes approved by the FDA

Bodle Technologies Secures Series A Funding Extension

Perspectum issued CPT® Codes for LiverMultiScan® by the American Medical Association to help Drs diagnose and treat liver disease

Clean nuclear: Oxford start-up 10 years ahead of government targets in race to build fusion plant

LifeArc co-leads £6 million funding in DJS Antibodies

MERRY CHRISTMAS FROM ALL THE TEAM AT OSI

Meet the Founder: Sumi Biswas, CEO of SpyBiotech

PepGen raises $45M in Series A funding, led by RA Capital

HEXR launches smartphone fitting app: Bespoke, 3D printed helmets now accessible to millions

Software Ate the World, and Soon It Will Write Itself – Wall Street Journal article by Diffblue

Counterfeit drugs and illegitimate vaccines, both costly and deadly, could be a thing of the past with new breakthrough testing technology from Proxisense and Oxford University

Refeyn Closes Series A Funding Round, led by Northpond Ventures

The Backstory: Vaccitech and its role in co-inventing the Oxford COVID-19 vaccine

BREAKTHROUGH FOR OXFORD’S COVID VACCINE, CO-INVENTED BY OSI PORTFOLIO COMPANY VACCITECH

Evox Therapeutics launch strategic collaboration with Oxford University to accelerate development of exosome therapies for rare diseases

Mind Foundry raises an additional $13.6 million in Series A funding led by Aioi Nissay Dowa Insurance

OSI UPDATES: AUTUMN 2020 NEWSLETTER

The Backstory: Base Genomics and their mission to defeat cancer through early diagnosis

Oxford Sciences Innovation announces the sale of Base Genomics to Exact Sciences

Vaccitech expands management team with hires including CMO and CFO

Notice of Annual General Meeting

Fusion energy can be the most cost competitive source of baseload power, at the same level as renewables

Oxford Sciences Innovation appoints Alexis Dormandy as CEO

Scenic Biotech Enters into Genetic Modifier Collaboration with Genentech

3 portfolio companies win the NHSX AI in Healthcare Award

SpyBiotech and Serum Institute of India announce that the first subjects have been dosed in a Phase I/II trial of a novel virus-like particle vaccine targeting COVID-19

Biocentury feature: OSI leverages foundational deal with Oxford to build its life sciences portfolio

Celebrating five years of OSI and Oxford’s history of innovation

Meet the Founder: Ilana Wisby, CEO of Oxford Quantum Circuits

The genome only makes sense in 3D, by Lachlan Mackinnon

Orca Computing raises £2.9m in pre-seed funding for photonics quantum computer

Positive Phase 1 readout of Dr Sarah Gilbert covid vaccine

Cybersecurity in the age of quantum: Our investment in PQShield

Evox announces landmark partnerships with pharma giants Takeda and Eli Lilly

Welcome to the portfolio, Base Genomics!

A royal launch of our Grassroots incubator space!

Uciane Scarlett, our Life Sciences principal, on an inclusive biotech sector

Vaccitech CEO Bill Enright on the Oxford Covid-19 vaccine

Ultromics featured in the Wall Street Journal

Introducing the Scientist in Residence

Quantum Motion raises £8m in an oversubscribed Series A led by Inkef Capital

Vaccitech partners with the University of Oxford and AstraZeneca to develop a Covid-19 vaccine

Huma Health (formerly Medopad) acquires Biobeats to develop their mental health capabilities

Niantic acquires 6D.ai to develop their augmented reality platform

Congratulations OMass! Team raises £27.5m in additional Series A funding

Patrick Pichette to step down from OSI board, Chris Chambers announced as new chair

Latent Logic acquired by Waymo. Congratulations to the team!

MiroBio launches with £27m Series A!

Ten tools every developer should know in 2018 [Diffblue]

Genomics raises £25m as it announces deal with US pharma giant

10 outstanding start-ups from Oxford to watch

15 Machine Learning Companies To Watch In Europe

Navenio raises £9m for its hospital workforce AI platform

NHS to trial Uber-style location service to match up patients, porters and equipment

Updates

Sign up for OSI Quarterly for brief updates.

Follow us:

Connect

Stay up to date